Effect of Nitrous Oxide in Treating Neuropathic Pain: A Study in Chronic Low Back Pain Patients
NCT01172600 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2016-10-17
Summary
Epidural injection will be completed under fluoroscopy and all patients will receive 1-4 mg of Midazolam for relaxation before procedure and, if needed, 50-100 mcg of Fentanyl intravenous (IV). Radiopaque contrast (Omnipaque 300), for confirming the epidural position of the needle, steroids and local anesthetic agents will be used according to the physician performing the block and will not be controlled by the study. Patients will be randomly assigned to receive either inhaled Entonox along with the interventional block they are scheduled for or oxygen. They will be blinded about the treatment they are receiving. Those randomized to Entonox will inhale the gas through a mouthpiece throughout the procedure and also continue to receive it for a total of 4 hours in the recovery. Those randomized to the oxygen group will receive oxygen through a similar mouthpiece for the entire duration of the procedure and recovery for 4 hours. Following completion of procedure the patient will be transferred to recovery and monitored for 3-5 hours then discharged home with instructions. Possible side effects will be monitored and recorded, pain score of patient will be recorded before discharge. All the patients will receive standard instructions regarding physical back exercises. This will be repeated for every procedure up to maximum of three blocks.
The patients will be followed during each block and over a period of 1, 3, 6 and 12 months and on each follow-up visit will complete computerized set of questionnaires as they did before the procedure. The patients charts will be then reviewed for one year after the initial procedure to determine if further epidural steroid injections or surgery for the presenting problem were required. It is anticipated that the appropriate number of patients will be enrolled within six months of study initiation.
Conditions
- Low Back Pain
- Radiating Pain
Interventions
- OTHER
-
Entonox
Those randomized to Entonox will inhale the gas through a mouthpiece throughout the procedure and also continue to receive it for a total of 4 hours in the recovery.
- OTHER
-
Oxygen
Those randomized to oxygen will inhale it through a mouthpiece throughout the procedure and also continue to receive it for a total of 4 hours in the recovery.
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Principal Investigators
-
Alparslan Turan, M.D. · The Cleveland Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-03-31
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
NCT03727100 ·Status: COMPLETED ·Phase: PHASE3
-
Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients
NCT03301766 ·Status: WITHDRAWN ·Phase: PHASE4
-
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
NCT06306157 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Epidural Clonidine for Lumbosacral Radiculopathy
NCT00588354 ·Status: TERMINATED ·Phase: NA
-
Conus Medullaris Stimulation With 5 Columns Lead Versus Medical Treatment in Refractory Pudendal Neuralgia
NCT02564172 ·Status: COMPLETED ·Phase: NA
-
Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain
NCT02460692 ·Status: COMPLETED ·Phase: PHASE2
-
Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
NCT04238793 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet
NCT05614648 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin)
NCT01842126 ·Status: COMPLETED ·Phase: PHASE1
-
Diazepam Use With Standard Management for Acute Low Back Pain
NCT02646124 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study on the Efficacy of Infiltration of Upper Cluneal Nerves in Chronic Pain Related to Cluneal Syndrome
NCT05423132 ·Status: WITHDRAWN ·Phase: NA
-
The Effects of Topical Treatment With Clonidine + Pentoxifylline in Patients With Neuropathic Pain
NCT03342950 ·Status: TERMINATED ·Phase: PHASE2
-
The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin
NCT01669967 ·Status: COMPLETED ·Phase: NA
-
Effect of Abdominal Wall Injections on Abdominal Pain
NCT06121466 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain
NCT01752322 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain
NCT07122453 ·Status: RECRUITING ·Phase: PHASE1
-
Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)
NCT00916942 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain
NCT00414349 ·Status: COMPLETED ·Phase: PHASE3
-
Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
NCT02502162 ·Status: RECRUITING ·Phase: NA
-
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
NCT04678895 ·Status: RECRUITING ·Phase: PHASE2
-
Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain
NCT02217267 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
NCT01917825 ·Status: COMPLETED ·Phase: PHASE2
-
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
NCT06121232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Steroids Versus Gabapentin
NCT01495923 ·Status: COMPLETED ·Phase: NA